Vita Coco (NASDAQ: COCO) COO sells 30k shares under 10b5-1 plan

Rhea-AI Filing Summary

Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported an option-related share sale. He exercised stock options to acquire a total of 30,000 shares of common stock at an exercise price of $10.178 per share, then sold 30,000 shares at $80.00 per share in an open-market transaction.

The filing states that the stock sales were made under a pre-arranged Rule 10b5-1 trading plan. After these transactions, Burth directly holds 57,910 shares of Vita Coco common stock and retains multiple non-qualified stock option awards with various exercise prices and expiration dates.

Insider Trade Summary 10b5-1

Net Seller: 30,000 shares ($2,400,000)

Net Sell 12 txns

Insider Burth Jonathan

Role Chief Operating Officer

Sold 30,000 shs ($2.40M)

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (Right to Buy)	23,575	$0.00	--
Exercise	Non-Qualified Stock Option (Right to Buy)	6,425	$0.00	--
Exercise	Common Stock	23,575	$10.178	$240K
Exercise	Common Stock	6,425	$10.178	$65K
Sale	Common Stock	30,000	$80.00	$2.40M
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Non-Qualified Stock Option (Right to Buy) — 0 shares (Direct, null); Common Stock — 81,485 shares (Direct, null)

Footnotes (1)

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The stock option is fully vested and currently exercisable. The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

Key Figures

Shares sold: 30,000 shares Sale price: $80.00 per share Shares acquired via exercise: 30,000 shares +4 more

7 metrics

Shares sold 30,000 shares Common stock sale at $80.00 per share on June 11, 2026

Sale price $80.00 per share Open-market or private sale of 30,000 common shares

Shares acquired via exercise 30,000 shares Option exercises coded M at $10.1780 per share

Option exercise price $10.1780 per share Non-qualified stock options on common stock exercised

Shares held after 57,910 shares Direct common stock ownership following transactions

Remaining option block 58,043 underlying shares Non-qualified stock option at $15.0000, expiring October 21, 2031

Remaining option block 42,980 underlying shares Non-qualified stock option at $15.3600, expiring August 15, 2032

Key Terms

Rule 10b5-1 trading plan, Non-Qualified Stock Option (Right to Buy), derivative exercise/conversion, performance conditions, +1 more

5 terms

Rule 10b5-1 trading plan financial

"The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Non-Qualified Stock Option (Right to Buy) financial

"security_title": "Non-Qualified Stock Option (Right to Buy)""

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

performance conditions financial

"The stock option is eligible to vest if certain performance conditions are met by the target date"

vests in four equal annual installments financial

"The stock option vests in four equal annual installments beginning on March 10, 2024."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/12/2026 - 04:12 PM Accepted by SEC EDGAR 06/12/2026 - 04:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burth Jonathan

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NEW YORK 10003

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		M		23,575	A	$10.178	81,485	D
Common Stock	06/11/2026		M		6,425	A	$10.178	87,910	D
Common Stock	06/11/2026		S(1)		30,000	D	$80	57,910	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$10.178	06/11/2026		M			23,575	(2)	02/10/2030	Common Stock	23,575	$0	0	D
Non-Qualified Stock Option (Right to Buy)	$10.178	06/11/2026		M			6,425	(3)	02/10/2030	Common Stock	6,425	$0	34,525	D
Non-Qualified Stock Option (Right to Buy)	$10.178							(2)	01/11/2031	Common Stock	34,125		34,125	D
Non-Qualified Stock Option (Right to Buy)	$15							(4)	10/21/2031	Common Stock	58,043		58,043	D
Non-Qualified Stock Option (Right to Buy)	$15.36							(5)	08/15/2032	Common Stock	42,980		42,980	D
Non-Qualified Stock Option (Right to Buy)	$16.91							(6)	03/10/2033	Common Stock	14,025		14,025	D
Non-Qualified Stock Option (Right to Buy)	$16.91							(7)	03/10/2033	Common Stock	14,205		14,205	D
Non-Qualified Stock Option (Right to Buy)	$26.18							(8)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (Right to Buy)	$33.36							(9)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option is fully vested and currently exercisable.

3. The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.

4. The stock option vests in four equal annual installments beginning on November 27, 2022.

5. The stock option vests in three equal annual installments beginning on August 15, 2025.

6. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.

7. The stock option vests in four equal annual installments beginning on March 10, 2024.

8. The stock option vests in four equal annual installments beginning on March 4, 2025.

9. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	/s/ Alison Klein, Attorney-in-Fact for Jonathan Burth	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Vita Coco (COCO) report for COO Jonathan Burth?

Jonathan Burth exercised options and sold shares. He exercised stock options to acquire 30,000 Vita Coco common shares at $10.178 per share, then sold 30,000 shares at $80.00 per share in an open-market transaction on June 11, 2026.

How many Vita Coco (COCO) shares does the COO hold after this Form 4?

Burth holds 57,910 Vita Coco shares after the transactions. Following the option exercises and the sale of 30,000 common shares, his remaining direct ownership is 57,910 common shares, according to the reported post-transaction balance in the Form 4 data.

Were the Vita Coco (COCO) COO’s share sales made under a Rule 10b5-1 plan?

Yes, the sales were under a Rule 10b5-1 trading plan. A footnote states that the reported common stock sales were effected pursuant to a Rule 10b5-1 trading plan, indicating they were pre-arranged rather than timed discretionarily.

What option exercise prices are shown for Vita Coco (COCO) COO Jonathan Burth?

The Form 4 lists several option exercise prices. These include options with exercise prices such as $10.1780, $15.0000, $15.3600, $16.9100, $26.1800, and $33.3600, each tied to non-qualified stock options on Vita Coco common stock.

How many Vita Coco (COCO) shares did the COO sell and at what price?

He sold 30,000 Vita Coco common shares at $80.00 each. The Form 4 reports an open-market or private sale transaction of 30,000 shares of common stock at a transaction price per share of $80.0000.

What vesting conditions apply to some Vita Coco (COCO) stock options held by the COO?

Several options vest over time or on performance. Footnotes describe options vesting in equal annual installments beginning on dates such as November 27, 2022, and others vesting only if specified performance conditions are met by certain target dates, with some tranches already vested.